The Beyfortus Global Market Report 2025: Rising RSV Cases Driving Market Growth For Industry
The Business Research Company The Business Research Company's Beyfortus Global Market Report 2025 – Market Size, Trends, And Global Forecas ...
Future Market Insights3d
Respiratory Pathogen Testing Kits Market to Reach USD 7,136.8 Million by 2033, Growing at a 5.7% CAGR
The global respiratory pathogen testing kits market is projected to expand from USD 4,083.1 million in 2023 to USD 7,136.8 ...
PharmiWeb3d
Respiratory Pathogen Testing Kits Market to Reach USD 7,136.8 Million by 2033, Expanding at a 5.7% CAGR
Respiratory Pathogen Testing Kits MarketThe global respiratory pathogen testing kits market is projected to grow from USD 4,083.1 million in 2023 to USD 7,136.8 million by 2033, at a CAGR of 5.7%. The ...
Health Experts Sound Alarm as FDA Cancels Key Vaccine Meeting
Rumors are spreading all over the place.’ Experts fear the cancellation signals a sidelining of science at federal health ...
Science News3d
What experts say about childhood vaccines amid the Texas measles outbreak
As the Texas measles outbreak grows and HHS head RFK Jr. puts vaccines under new scrutiny, two experts answer questions about the public health tool.
Winston-Salem Journal3d
311 North Carolinians have died of flu so far this season
The overall number of respiratory virus cases in hospital emergency departments dropped for the second consecutive week — a ...
Moderna, Inc.: Moderna Receives Medicines and Healthcare Products Regulatory Agency Marketing Authorization in the UK for RSV Vaccine
RESVIA® is Moderna's second approved product in the UK CAMBRIDGE, MA / ACCESS Newswire / February 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regu ...
The Tribune-Democrat4dOpinion
George Hancock | January moved out with brutal punch
January was a brutal month. I started our new year with a viral infection that lingered for weeks. A trip to the doctor’s ...
FDA Drags Heels on Vaccine Plans
The Department of Health and Human Services told Newsweek that it is "necessary to review agreements for vaccine production." ...
Moderna's stock stumbles on report HHS is reviewing $590 million award for bird-flu vaccine
The news was reported by Bloomberg late Wednesday, citing people familiar with the matter. In the final days of President Joe Biden's term, Moderna (MRNA) won the $590 million contract to use its mRNA ...
Moderna's stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award
Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...